Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
國立臺灣大學
/
醫學院
/
臨床醫學研究所
Clinical Medicine
瀏覽統計
Email 通知
RSS Feed
關於
子單位
研究人員
14
研究成果
3561
計畫
868
單位人員研究成果
顯示/隱藏過濾條件
依作者
11
jia-horng kao
2
ding-shinn chen
1
chi-ling chen
1
chun-jen liu
1
hsu, yao-chun
1
huang, chiuan-bo
1
kao c.-n.
1
lin, meng-ju
1
nguyen, mindie h
1
pei-jer chen
.
下一頁 >
主題
6
[sdgs]sdg3
1
cancer risk; chronic hepatitis; evidence based medicine; hepatitis b; human; human immunodeficiency virus infection; incidence; letter; meta analysis (topic); multiple myeloma; priority journal; risk factor; validation process; b lymphocyte; chronic hepatitis b; hepatitis b virus; nonhodgkin lymphoma; b-lymphocytes; hepatitis b; hepatitis b virus; hepatitis b, chronic; humans; lymphoma, non-hodgkin; multiple myeloma
1
ceftriaxone; lamivudine; mannitol; adult; case report; comorbidity; conservative treatment; fatty liver; female; hepatitis b; hepatitis b virus; human; human tissue; hyperbilirubinemia; letter; liver biopsy; pregnancy; priority journal
1
circular dna; covalently closed circular dna; entecavir; unclassified drug; antivirus agent; alcohol liver disease; antiviral therapy; cancer incidence; cancer patient; cancer risk; chronic hepatitis b; hepatitis b virus; human; letter; liver cell; liver cell carcinoma; liver cirrhosis; mortality rate; patient risk; priority journal; treatment duration; vaccination; virus replication; chronic hepatitis b; hepatitis b virus; liver cell carcinoma; liver tumor; treatment outcome; antiviral agents; carcinoma, hepatocellular; hepatitis b virus; hepatitis b, chronic; humans; liver cirrhosis; liver neoplasms; treatment outcome
1
entecavir; antivirus agent; entecavir; guanine; virus dna; acute hepatitis a; antiviral therapy; cancer risk; child pugh score; chronic hepatitis b; decompensated liver cirrhosis; drug response; hepatitis e; human; incidence; letter; liver cell carcinoma; liver cirrhosis; mortality; public health service; risk reduction; superinfection; survival; taiwan; analogs and derivatives; chronic hepatitis b; genetics; hepatitis b virus; liver cell carcinoma; liver cirrhosis; liver tumor; antiviral agents; carcinoma, hepatocellular; dna, viral; guanine; hepatitis b virus; hepatitis b, chronic; humans; liver cirrhosis; liver neoplasms
1
entecavir; hepatitis b surface antigen; interferon; peginterferon; virus rna; alpha interferon; antivirus agent; hepatitis b surface antigen; hepatitis b(e) antigen; interferon; recombinant protein; virus dna; delta agent hepatitis; drug hypersensitivity; drug safety; drug withdrawal; hepatitis b virus; hepatitis delta virus; human; letter; liver cirrhosis; liver injury; nonhuman; priority journal; treatment duration; treatment response; treatment withdrawal; viral clearance; chronic hepatitis b; delta agent hepatitis; genetics; kinetics; antiviral agents; dna, viral; hepatitis b e antigens; hepatitis b surface antigens; hepatitis b virus; hepatitis b, chronic; hepatitis d, chronic; humans; interferon-alpha; interferons; kinetics; recombinant proteins
1
hepatitis b; liver; meta-analysis
1
interferon; ribavirin; antiviral therapy; disease course; drug tolerance; hepatitis b; hepatitis b virus; human; letter; liver fibrosis; long term care; priority journal; survival; treatment outcome; treatment response; antiviral agents; aspartate aminotransferases; hepatitis c, chronic; humans; interferons; platelet count; predictive value of tests
依日期
6
2020 - 2024
3
2010 - 2019
2
2007 - 2009
全文
11
no fulltext
關閉過濾條件
再查詢
資料類型:
letter
作者:
tung-hung su
第 1 到 11 筆結果,共 11 筆。
公開日期
標題
作者
來源出版物
scopus
WOS
全文
1
2024
Reply
SHANG-CHIN HUANG
; TUNG-HUNG SU
; JIA-HORNG KAO
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
2
2024
Reply to “Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy”
Lin, Meng-Ju; TUNG-HUNG SU
; JIA-HORNG KAO
Journal of the Formosan Medical Association = Taiwan yi zhi
0
0
3
2023
Gamma-glutamyl transferase levels in the prediction of the outcomes of hepatocellular carcinoma after surgical resection
TUNG-HUNG SU
; JIA-HORNG KAO
Journal of the Formosan Medical Association = Taiwan yi zhi
0
0
4
2023
Anti-HBc level predicting virological relapse after stopping nucleos(t)ide analogue in chronic hepatitis B
Huang, Chiuan-Bo; TUNG-HUNG SU
; JIA-HORNG KAO
Liver international : official journal of the International Association for the Study of the Liver
1
1
5
2022
Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities
Hsu, Yao-Chun; Tseng, Cheng-Hao; TUNG-HUNG SU
; JIA-HORNG KAO
; Nguyen, Mindie H
Gut
3
2
6
2020
letter: hepatitis B virus infection and risk of multiple myeloma—a meta-analysis of cohort studies. Authors' reply
TUNG-HUNG SU
; CHI-LING CHEN
; JIA-HORNG KAO
Alimentary Pharmacology and Therapeutics
0
0
7
2018
HCC risk in patients with HBV-related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed?
TUNG-HUNG SU
; TAI-CHUNG TSENG
; JIA-HORNG KAO
Hepatology
11
10
8
2017
Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
TUNG-HUNG SU
; JIA-HORNG KAO
Liver International
2
2
9
2017
letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D
Kao C.-N.; TUNG-HUNG SU
; JIA-HORNG KAO
Alimentary Pharmacology and Therapeutics
1
1
10
2008
Acute fatty liver of pregnancy with concurrent acute hepatitis B virus infection
TUNG-HUNG SU
; CHUN-JEN LIU
; PEI-JER CHEN
; DING-SHINN CHEN
; JIA-HORNG KAO
American Journal of Gastroenterology
0
0
11
2007
APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers [5]
TUNG-HUNG SU
; JIA-HORNG KAO
; DING-SHINN CHEN
Hepatology
0
0